Suppr超能文献

一项前瞻性多中心全球研究:胰腺手术联合血管切除的短期预后分析

Analysis of Short-Term Outcomes in Pancreatic Surgery with Vascular Resection from a Prospective Multicenter Global Study.

作者信息

Tinguely Pascale, Hidalgo Salinas Camila, Staubli Sebastian M, Raptis Dimitri A, Fusai Giuseppe K

机构信息

Department Of HPB Surgery and Liver Transplant, Royal Free Hospital NHS Foundation Trust, London, UK.

Centre For Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford, UK.

出版信息

Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-17911-8.

Abstract

BACKGROUND

Pancreatic resection with concomitant vascular resection is increasingly practiced with outcomes mainly reported from specialist centers but lacking results from prospective global data. This study aimed to investigate factors associated with short-term outcomes after vascular resections in pancreatic surgery worldwide.

PATIENTS AND METHODS

Data were extracted from a prospective, multicenter, international cross-sectional snapshot study in 2021 (pancreasgroup.org) assessing short-term outcomes after pancreatic surgery worldwide (NCT04652271). In the patient cohort of pancreatic surgery with simultaneous vascular resection for various diseases, short-term outcomes were reported and compared with established benchmark values. Factors affecting major complications, mortality, and histopathological resection status were assessed in multivariable logistic regression analyses with interaction testing.

RESULTS

From a total of 3926 patients undergoing pancreatic surgery, 565 had associated vascular resections, of which 444 had venous resections alone and 121 had arterial resections alone or with concomitant venous resection. Of the 153 (47%) benchmark cases with pancreatoduodenectomy and venous resection, median postoperative morbidity fell within established benchmark criteria. Median 90-day major complication and mortality rates were similar in pancreatic resection with venous, arterial or no vascular resections (45 and 10%, 47 and 6.6%, 42 and 9.6% respectively). Patients undergoing arterial resections that developed a clinically relevant pancreatic fistula faced substantially elevated odds of 90-day mortality (OR 8.8 CI 1.6-48). In pancreatic ductal adenocarcinoma, the R1 rate was 26%, neoadjuvant chemotherapy being protective for both overall and venous-specific margins.

CONCLUSIONS

Vascular pancreatic surgery is performed across diverse healthcare settings worldwide. While perioperative complications were comparable to nonvascular pancreatic resections, the observed 90-day mortality was considerable overall. International collaborative efforts should focus on understanding practice variations and improve accessibility of optimal perioperative care to promote rescue capabilities.

摘要

背景

胰腺切除联合血管切除的手术越来越普遍,其结果主要来自专科中心的报告,但缺乏前瞻性全球数据的结果。本研究旨在调查全球胰腺手术中血管切除术后短期预后的相关因素。

患者与方法

数据来自2021年一项前瞻性、多中心、国际横断面快照研究(pancreasgroup.org),该研究评估了全球胰腺手术后的短期预后(NCT04652271)。在因各种疾病同时进行血管切除的胰腺手术患者队列中,报告了短期预后并与既定的基准值进行比较。在多变量逻辑回归分析和交互作用测试中评估了影响主要并发症、死亡率和组织病理学切除状态的因素。

结果

在总共3926例接受胰腺手术的患者中,565例进行了相关血管切除,其中444例仅进行了静脉切除,121例仅进行了动脉切除或同时进行了静脉切除。在153例(47%)胰十二指肠切除术和静脉切除的基准病例中,术后发病率中位数在既定基准标准范围内。在进行静脉、动脉或无血管切除的胰腺切除术中,90天主要并发症和死亡率中位数相似(分别为45%和10%、47%和6.6%、42%和9.6%)。发生临床相关胰瘘的动脉切除患者90天死亡率的几率大幅升高(OR 8.8,CI 1.6 - 48)。在胰腺导管腺癌中,R1切除率为26%,新辅助化疗对总体切缘和静脉切缘均有保护作用。

结论

血管胰腺手术在全球不同的医疗环境中开展。虽然围手术期并发症与非血管胰腺切除相当,但总体观察到的90天死亡率较高。国际合作应专注于了解实践差异,并提高获得最佳围手术期护理的可及性,以提升救治能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验